Brendler CB - Search Results

1

Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy.

Partin AW, Piantadosi S, Sanda MG, Epstein JI, Marshall FF, Mohler JL, Brendler CB, Walsh PC, Simons JW. Partin AW, et al. Among authors: brendler cb. Urology. 1995 May;45(5):831-8. doi: 10.1016/S0090-4295(99)80091-0. Urology. 1995. PMID: 7538245

2

The value of serum enzymatic acid phosphatase in the staging of localized prostate cancer.

Burnett AL, Chan DW, Brendler CB, Walsh PC. Burnett AL, et al. Among authors: brendler cb. J Urol. 1992 Dec;148(6):1832-4. doi: 10.1016/s0022-5347(17)37042-8. J Urol. 1992. PMID: 1279226 Free article.

3

The role of radical prostatectomy in the treatment of prostate cancer.

Brendler CB, Walsh PC. Brendler CB, et al. CA Cancer J Clin. 1992 Jul-Aug;42(4):212-22. doi: 10.3322/canjclin.42.4.212. CA Cancer J Clin. 1992. PMID: 1623431 Free article.

4

Ileocolic neobladder post-cystectomy: continence and potency.

Marshall FF, Mostwin JL, Radebaugh LC, Walsh PC, Brendler CB. Marshall FF, et al. Among authors: brendler cb. J Urol. 1991 Mar;145(3):502-4. doi: 10.1016/s0022-5347(17)38380-5. J Urol. 1991. PMID: 1997699 Free article.

5

Advanced small cell carcinoma of the bladder. Successful treatment with combined radical cystoprostatectomy and adjuvant methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy.

Oesterling JE, Brendler CB, Burgers JK, Marshall FF, Epstein JI. Oesterling JE, et al. Among authors: brendler cb. Cancer. 1990 May 1;65(9):1928-36. doi: 10.1002/1097-0142(19900501)65:9<1928::aid-cncr2820650910>3.0.co;2-x. Cancer. 1990. PMID: 2164873

6

Local recurrence and survival following nerve-sparing radical cystoprostatectomy.

Brendler CB, Steinberg GD, Marshall FF, Mostwin JL, Walsh PC. Brendler CB, et al. J Urol. 1990 Nov;144(5):1137-40; discussion 1140-1. doi: 10.1016/s0022-5347(17)39675-1. J Urol. 1990. PMID: 2231885

7

Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.

Oesterling JE, Chan DW, Epstein JI, Kimball AW Jr, Bruzek DJ, Rock RC, Brendler CB, Walsh PC. Oesterling JE, et al. Among authors: brendler cb. J Urol. 1988 Apr;139(4):766-72. doi: 10.1016/s0022-5347(17)42630-9. J Urol. 1988. PMID: 2451037

8

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.

Epstein JI, Walsh PC, Carmichael M, Brendler CB. Epstein JI, et al. Among authors: brendler cb. JAMA. 1994 Feb 2;271(5):368-74. JAMA. 1994. PMID: 7506797

9

Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C).

Epstein JI, Walsh PC, Brendler CB. Epstein JI, et al. Among authors: brendler cb. J Urol. 1994 Nov;152(5 Pt 2):1721-9. doi: 10.1016/s0022-5347(17)32370-4. J Urol. 1994. PMID: 7523719 Free article. Review.

10

The use of nuclear morphometry in predicting recurrence of transitional cell carcinoma.

Borland RN, Partin AW, Epstein JI, Brendler CB. Borland RN, et al. Among authors: brendler cb. J Urol. 1993 Feb;149(2):272-5. doi: 10.1016/s0022-5347(17)36053-6. J Urol. 1993. PMID: 8426399 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

154 results

Search Page

Filters